The effects of Byrsonima crassifolia extracts on the enteric nervous system were evaluated according to the method described elsewhere (Lozoya et al.
Although Byrsonima crassifolia has been used to treat some mental-related diseases in traditional medicine, its specific neuropharmacological activities have not been demonstrated yet.
2002, 2005, 2009), is between 500 and 1000 mg/kg of plant extracts, the dose-dependent assay show that Byrsonima crassifolia appears to be within a similar range of potency.
These doses were lower than those employed in this study of Byrsonima crassifolia.
Although quercetin and some of its glycosides had been found in Byrsonima crassifolia, the presence of quercetin 3-O-xyloside as the main compound in BcMeOH had not been reported previously.
2000) have been reported to be the main compounds in Byrsonima crassifolia, and thus, the best of our knowledge, this is the first report of the presence of rutin and hesperidin flavonoids in the Byrsonima crassifolia species.
To the best of our knowledge, the present study constitutes the first report of the presence of the neuroactive flavonoids rutin and hesperidin in Byrsonima crassifolia.
Constituents of Byrsonima crassifolia, and their spasmogenic activity.